Acorda Therapeutics (ACOR) Stock Moves -0.11%: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Acorda Therapeutics (ACOR) closed at $0.93 in the latest trading session, marking a -0.11% move from the prior day. This move was narrower than the S&P 500’s daily loss of 0.16%. Meanwhile, the Dow lost 0.12%, and the Nasdaq, a tech-heavy index, lost 0.33%.

Prior to today’s trading, shares of the drugmaker had lost 10.58% over the past month. This has lagged the Medical sector’s loss of 8.16% and the S&P 500’s loss of 10.5% in that time.

ACOR will be looking to display strength as it nears its next earnings release. In that report, analysts expect ACOR to post earnings of -$0.35 per share. This would mark year-over-year growth of 37.5%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $39.34 million, down 10.87% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$1.03 per share and revenue of $137.11 million, which would represent changes of +40.12% and -28.74%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for ACOR. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.

Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Home of Science
Follow me

Latest posts by Home of Science (see all)
- Advertisement -

Discover

Sponsor

Latest

Netflix and Snap earnings will be different tales of media usage during coronavirus

Snap Inc. and Netflix Inc. have seen increased usage as the COVID-19 pandemic forces people to entertain themselves at home, but only one is...

Target CEO: We want to be the safest place to shop in America

Historically, if you ask any retail executive what they want to be known for by consumers, the quick answer is usually something like: “We...

U.S. taxpayers set to be major investors in the struggling airline industry

The U.S. taxpayer will be a major player in the struggling airline industry, as many carriers are set to receive government aid with conditions...

Symptoms of Mesothelioma – Commonly Found Symptoms of Mesothelioma

Symptoms of Mesothelioma - Commonly Found Symptoms of MesotheliomaIf you are interested in learning more about mesothelioma, the disease that affects the mesothelium,...

Top 5 Shows of 2020

Top 5 Shows of 2020Who's excited for the hottest shows of 2020? As we all know, the TV show world is a competitive...
Home of Science
Follow me
Latest posts by Home of Science (see all)